Researchers say a new drug-delivery implant could help patients with hard-to-treat bladder cancer avoid losing their bladders — and stay cancer-free for years.
The triplet therapy was effective only in patients with nonmutated PIK3CA and ESR1 genes, achieving a median PFS of 9.1 ...
Money Talks News on MSN
$32K Alzheimer drugs offer modest brain benefits
Controversial anti-amyloid therapies costing up to $32,000 annually offer modest hope for Alzheimer's patients while carrying ...
News Medical on MSN
Sertraline contributes to a modest improvement in core depression and anxiety symptoms
One of the most common antidepressants, sertraline, contributes to a modest improvement in core depression and anxiety symptoms, including low mood, within two weeks, finds a new analysis of a major ...
The investigational, potentially first-in-class agent tinostamustine (EDO-S101) has earned FDA orphan drug designation (ODD) ...
In a 36-year-old woman with a resected 5-cm, node-negative, estrogen-receptor (ER)-negative, progesterone-receptor (PR)-positive, HER2-neu-negative breast cancer, is there a role for the addition of ...
ScienceAlert on MSN
Alzheimer's Disease Could Be Slowed by Taking as Few as 5,000 Steps a Day
Taking a pleasant daily stroll could help slow the protein buildup and cognitive decline associated with Alzheimer's disease, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results